Methods of treating left ventricular diastolic dysfunction (LVDD) and heart failure with preserved ejection fraction (HFPEF)
TW202639136APending Publication Date: 2026-10-01MINERALYS THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115100855
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-11-07
- Filing Date
- 2026-01-09
- Publication Date
- 2026-10-01
Smart Images
Figure 00000000_0000_ABST
Abstract
This invention relates to a method of treating heart failure with preserved ejection fraction (HFpEF) in a subject afflicted with HFpEF, the method comprising administering to the subject an aldosterone synthase inhibitor once per day in an amount effective to treat HFpEF in the subject. This invention also relates to a method of treating left ventricular diastolic dysfunction (LVDD) in a subject afflicted with LVDD, the method comprising administering to the subject an aldosterone synthase inhibitor once per day in an amount effective to treat LVDD in the subject.
Need to check novelty before this filing date? Find Prior Art